Increases in tobacco exposure biomarkers measured in non-smokers exposed to sidestream cigarette smoke under controlled conditions

Biomarkers

Volumn 14, Issue 2, 2009, Pages 82-93

  Bernert, John T ^a   Gordon, Sydney M ^b   Jain, Ram B ^a   Brinkman, Marielle C ^b   Sosnoff, Connie S ^a   Seyler, Tiffany H ^a   Xia, Yang ^a   McGuffey, James E ^a   Ashley, David L ^a   Pirkle, James L ^a   Sampson, Eric J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

4 aminobiphenyl; Adducts; Cigarette smoking; Cotinine; ETS; Exposure chamber; Nicotine; NNAL; Passive smoking; Secondhand smoke; SHS

Indexed keywords

4 BIPHENYLAMINE; BUTANOL; CIGARETTE SMOKE; COTININE; HEMOGLOBIN; NICOTINE; NITROSAMINE 4 (METHYLNITROSOAMINO) 1 (3 PYRIDYL) 1 BUTANOL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PASSIVE SMOKING; SEX DIFFERENCE; TOBACCO; URINALYSIS; ENVIRONMENTAL EXPOSURE; METABOLISM; SMOKE;

NICOTIANA TABACUM;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; HUMANS; SMOKE; TOBACCO;

EID: 66149140662     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902774613     Document Type: Article

References (34)

1. Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS. 2001. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst 93:378-381.
2. Airoldi L, Vineis P, Colombi Am, Ogiati L, Dell'Osta C, Fanelli R. et al. 2005. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition Prospective study. Can Epidemiol Biomark Prevent 14:2118-2124. (Pubitemid 41603255)
3. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the US population: Implications for urinary biological monitoring measurements. Environ Health Perspect 113:192-200.
4. Benowitz NL, Perez-Stable J, Fong I, Modin G, Herrera B, Jacob P. 1999. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Therap 291:1196-1203.
5. Benowitz JL, Herrera B, Jacob P. 2004. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Therap 310:1208-1215.
6. Bernert JT, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK. et al. 1997. Development and validation of a sensitive method for the determination of serum cotinine in both smokers and non-smokers by using liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 43:2281-2291.
7. Bernert JT, McGuffey JE, Morrison MA, Pirkle JL. 2000. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography/tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and non-smokers. J Anal Toxicol 24:333-339.
8. Bernert JT, Harmon T, Sosnoff CS, McGuffey JE.2005a. Use of cotinine immunoassay test strips for preclassifying urine samples from smokers and non-smokers prior to analysis by LC-MS-MS. J Anal Toxicol 29:814-818.
9. Bernert JT, Jain RB, Pirkle JL, Wang L, Miller BB, Sampson EJ.2005b. Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine Tobacco Res 7:729-738.
10. Borgerding MF, Bodnar JA, Wingate DE. 2000. The 1999 Massachusetts Benchmark Study - the Final Report. Conducted for the Massachusetts Department of Public Health by the Tobacco Industry. Boston, MA: Massachusetts Department of Public Health.
11. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. 1987. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47:602-608.
12. Bryant MS Vineis P, Skipper PL, Tannenbaum SR. 1988. Hemoglobin adducts of aromatic amines: Associations with smoking status and type of tobacco. Proc Natl Acad Sci 85:9788-9791.
13. Caraballo RS, Giovino GA, Pechachek TF, Mowery PD, Richter PA, Strauss WJ. et al. 1998. Racial and ethnic differences in serum cotinine levels of cigarette smokers. Third National Health and Nutrition Examination Survey. JAMA 280:135-139.
14. Dempsey D, Tutka P, Jacob P, Allen F, Schoedel K, Tyndale RF, Benowitz NL. 2004. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 76:64-72.
15. DHHS (U.S. Department of Health and Human Services). 2006. The health consequences of involuntary exposure to tobacco smoke: A report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
16. Gardiner PS. 2004. The African Americanization of menthol cigarette use in the United States. Nicotine Tobacco Res 6 (Suppl. 1):S55-S65.
17. Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR. 1993. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in non-smokers. J Natl Can Inst 85:474-478 (Pubitemid 23084092)
18. Hecht SS, Carmella S, Murphy SE, Akerkar S, Brunnemann KD, Hoffman D. 1993. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. New Engl J Med 329:1543-1546.
19. Hecht SS. 2004. Carcinogen derived biomarkers: Applications in studies of human exposure to secondhand tobacco smoke. Tobacco Cont 13(Suppl. 1):i48-i56.
20. Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, Greaves IA, Church TR, Ryan AD, Mongin SJ, Sexton K. 2001. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Can Epidemiol Biomark Prevent 10:1109-1116. (Pubitemid 33064297)
21. Hecht SS 2002. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:907-922.
22. Hukkanen J, Jacob P, Benowitz NL. 2005. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79-115.
23. Jarvis MJ, Russell MAH, Feyerabend C. 1983. Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure. Thorax 38:829-833.
24. Johnson LC, Letzel H, Kleinschmidt J. 1985. Passive smoking under controlled conditions. Int Arch Occup Environ Health 56:99-110.
25. Neter J, Wasserman W. 1974. Applied Linear Statistical Models: Regression, Analysis of Variance and Experimental Designs. Homewood, IL: Irwin.
26. Perez-Stable EJ, Herrera B, Jacob P, Benowitz NL. 1998. Nicotine metabolism and intake in black and white smokers. JAMA 280:152-156.
27. Pickett MS, Schober SE, Brody DJ, Curtin LR, Giovino GA. 2006. Smoke-free laws and secondhand smoke exposure in US nonsmoking adults, 1999-2002. Tob Control 15:302-307.
28. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. 2006. Trends in the exposure of non-smokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect 114:853-858.
29. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. 1996. Exposure of the US population to environmental tobacco smoke.The Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 275:1233-1240.
30. Singer BC, Hodgson AT, Guevarra KS, Hawley EL, Nazaroff WW. 2002. Gas-phase organics in environmental tobacco smoke. 1. Effects of smoking rate, ventilation, and furnishing level on emission factors. Environ Sci Technol 36:846-853.
31. Stankus RP, Menon PK, Rando RJ, Glindmeyer H, Salvaggio JE, Lehrer SB. 1988. Cigarette smoke-sensitive asthma: Challenge studies. J Allergy Clin Immunol 82:331-338.
32. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, Jacobs DR. 1990. Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health 80:1053-1056.
33. Willes SR, Fitgerald TK, Permutt T, Proud D, Haley NJ, Bascom R. 1998. Acute respiratory response to prolonged moderate levels of sidestream tobacco smoke. J Toxicol Environ Health 53:193-209.
34. Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, Bernert JT. 2005. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem 77:7639-7645.